Klinikum der Universität München Campus Grosshadern

München 81377

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumor, Gastric and Gastroesophageal Junction Adenocarcinoma, KRAS p.G12C Mutant Advanced Solid Tumors, Minimal Residual Disease Positive AML, Moderate Aortic Valve Stenosis, Myelodysplastic Syndrome, Relapsed/Refractory AML

Studies at this site

• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies — Stopped early
• Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma — Stopped early